Brevan Howard Capital Management LP Ocular Therapeutix, Inc Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 24,078 shares of OCUL stock, worth $175,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,078Holding current value
$175,287% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
186Shares Held
136MCall Options Held
284KPut Options Held
156K-
Summer Road LLC West Palm Beach, FL13.9MShares$101 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$93.4 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$92.9 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$83.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$61.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $560M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...